Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
GIP has been shown to decrease food intake while blunting the metabolic adaptive responses that usually occur with calorie restriction resulting in weight reductions, and when combined with GLP-1 receptor agonism, may result in greater effects on markers of metabolic dysregulation such as body weight, glucose and lipids
Hence, targeting these metabolic pathways offers the opportunity for developing anticoagulation therapies to avoid recurring events
Bruttel VS, Wischhusen J
& Gupta, S
& Deutscher, M
US$ 24.21
US$ 20.81
US$ 28.18
